This research demonstrates a novel DNA nanomachine that enhances sensing of extracellular metabolites, suggesting improved disease monitoring.
Dynamic monitoring of small-molecule metabolites in extracellular microenvironments is crucial for deciphering their roles as pathological regulators in disease progression. Despite their promise, DNA-based nanosensors remain constrained by insufficient sensitivity, structural instability, and poor signal output thresholds in spatially resolved extracellular biomarker imaging. Herein, we report a centipede-mimetic DNA nanomachine (CMNM) featuring (1) topologically engineered circular sensing modules that enhance nuclease stability and target recognition sensitivity and (2) a multibranched DNA nanowire scaffold with a morphology like a centipede, self-assembled by membrane-anchoring aptamers, enabling high-density sensor confinement at living cell surfaces via multivalent interactions. By reprogramming the recognition domains of the circular sensing modules, the CMNM enables spatial imaging of extracellular ATP and H+ in tumor cell environments and, notably, achieves the first DNA nanodevice-based visualization of extracellular lactate. This biomimetic and modular design strategy offers a versatile platform for expanding to a broader range of metabolic targets, paving the way for mechanistic studies of metabolic diseases and the development of precision diagnostic and therapeutic tools.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: